Nonketotic hyperglycemia due to prednisone (NSC-10023) following ketotic hyperglycemia due to L-asparaginase (NSC-109229) plus prednisone.
D000293:Adolescent; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced* / Q000150:complications; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D007970:Leukopenia / Q000209:etiology; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D011241:Prednisone / Q000009:adverse effects* / Q000627:therapeutic use; D012075:Remission, Spontaneous
D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone